We confirmed that miR-23a-5p functions as an upstream regulator of RAGE through sequencing and in vitro and in vivo models of COPD, which collectively illustrated that miR-23a-5p may potentially confer therapeutic effects to alleviate COPD. Here, AGER is linked to chronic obstructive pulmonary disease.